Literature DB >> 1392426

Cause and frequency of posttransfusion hepatitis after open-heart surgery.

H J Schlayer1, T Peters, S Preisler, H Berthold, W Gerok, J Rasenack.   

Abstract

A total of 1476 patients who underwent open-heart surgery between 1986 and 1988 participated in a prospective study examining posttransfusion hepatitis. They received a total of 8327 units of whole blood, packed erythrocytes, or fresh frozen plasma. The aminotransferase activities were measured preoperatively and 1, 2, 3, 4, 6, 9, 12, and 24 weeks after the operation. Thirty-four patients in all (2.3% of the transfused patients) developed posttransfusion hepatitis, which could be identified as hepatitis B in 1 patient and hepatitis C in 14 patients. No cause for posttransfusion hepatitis could be found in 19 cases (hepatitis of unknown origin). Hepatitis C became chronic in 5 patients. In contrast to hepatitis C, the 19 patients with hepatitis of unknown origin all showed a milder clinical course with lower maximal aminotransferase activities and a shorter duration of the hepatitis. A chronic course was not observed among them. The cause of hepatitis of unknown origin is discussed.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1392426     DOI: 10.1007/bf00184796

Source DB:  PubMed          Journal:  Clin Investig        ISSN: 0941-0198


  18 in total

1.  Anti-hepatitis C antibodies in prospectively followed-up transfused patients.

Authors:  A M Couroucé; A M Jullien; J B Vedrenne; B Habibi
Journal:  Vox Sang       Date:  1990       Impact factor: 2.144

2.  Long-term follow-up of posttransfusion and sporadic chronic hepatitis non-A, non-B and frequency of circulating antibodies to hepatitis C virus (HCV).

Authors:  U Hopf; B Möller; D Küther; R Stemerowicz; H Lobeck; A Lüdtke-Handjery; E Walter; H E Blum; M Roggendorf; F Deinhardt
Journal:  J Hepatol       Date:  1990-01       Impact factor: 25.083

3.  Post-transfusion hepatitis in Australia. Report of the Australian Red Cross study.

Authors:  Y E Cossart; S Kirsch; S L Ismay
Journal:  Lancet       Date:  1982-01-23       Impact factor: 79.321

4.  An outbreak of hepatitis associated with intravenous injection of factor-VIII concentrate.

Authors:  J Craske; N Dilling; D Stern
Journal:  Lancet       Date:  1975-08-02       Impact factor: 79.321

5.  Anti-hepatitis C antibodies and non-A, non-B post-transfusion hepatitis in The Netherlands.

Authors:  C L van der Poel; H W Reesink; P N Lelie; A Leentvaar-Kuypers; Q L Choo; G Kuo; M Houghton
Journal:  Lancet       Date:  1989-08-05       Impact factor: 79.321

6.  Post-transfusion non-A, non-B hepatitis after cardiac surgery. Prospective analysis of donor blood anti-HBc antibody as a predictive indicator of the occurrence of non-A, non-B hepatitis in recipients.

Authors:  J P Aymard; G Janot; S Gayet; C Guillemin; P Canton; P Gaucher; F Streiff
Journal:  Vox Sang       Date:  1986       Impact factor: 2.144

7.  Posttransfusion non-A, non-B hepatitis: physicochemical properties of two distinct agents.

Authors:  D W Bradley; J E Maynard; H Popper; E H Cook; J W Ebert; K A McCaustland; C A Schable; H A Fields
Journal:  J Infect Dis       Date:  1983-08       Impact factor: 5.226

8.  Prospective study of post-transfusion hepatitis after cardiac surgery in a British centre.

Authors:  J D Collins; M F Bassendine; A A Codd; A Collins; R E Ferner; O F James
Journal:  Br Med J (Clin Res Ed)       Date:  1983-11-12

9.  An assay for circulating antibodies to a major etiologic virus of human non-A, non-B hepatitis.

Authors:  G Kuo; Q L Choo; H J Alter; G L Gitnick; A G Redeker; R H Purcell; T Miyamura; J L Dienstag; M J Alter; C E Stevens
Journal:  Science       Date:  1989-04-21       Impact factor: 47.728

10.  Mutliple hepatitis viruses in multiple attacks of acute viral hepatitis.

Authors:  J W Mosley; A G Redeker; S M Feinstone; R H Purcell
Journal:  N Engl J Med       Date:  1977-01-13       Impact factor: 91.245

View more
  1 in total

1.  Sequence analysis of hepatitis B virus DNA in immunologically negative infection.

Authors:  S Preisler-Adams; H J Schlayer; T Peters; F Hettler; W Gerok; J Rasenack
Journal:  Arch Virol       Date:  1993       Impact factor: 2.574

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.